Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
CH0100191136
Wed, 28.07.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Regulatory Approval Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Aviptadil in Nation of Georgia 28.07.2021 / 07:15 Relief Reports that its U.S. Collaboration Partner has Announced Emergency Use Authorization of Avipt [ … ]
Technical analysis
To the publication
Wed, 28.07.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Takeover Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita 28.07.2021 / 07:00 Relief and AdVita Close Definitive Agreement for Relief to Acquire All Outstanding Shares of AdVita Acquisition Expands Scope of Developm [ … ]
Technical analysis
To the publication
Mon, 26.07.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Financing Relief Therapeutics Announces CHF 15 Million Private Placement 26.07.2021 / 07:00 Relief Therapeutics Announces CHF 15 Million Private Placement   Geneva, Switzerland, July 26, 2021 - RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF) ("Relief" or the [ … ]
Technical analysis
To the publication
Fri, 23.07.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Miscellaneous Relief Reports that its U.S. Collaboration Partner has Announced Successful Commercial Formulation for Aviptadil 23.07.2021 / 07:00 Relief Reports that its U.S. Collaboration Partner has Announced Successful Commercial Formulation for Aviptadil Geneva, [ … ]
Technical analysis
To the publication
Thu, 22.07.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Capital Increase Relief Announces Issuance of Shares from Authorized Capital as Approved by 2021 Annual General Meeting 22.07.2021 / 07:00 Relief Announces Issuance of Shares from Authorized Capital as Approved by 2021 Annual General Meeting Shares being used in par [ … ]
Technical analysis
To the publication
Tue, 20.07.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study results Relief Reports that its U.S. Collaboration Partner has Presented Evidence that Aviptadil Helps to Prevent Cytokine Storm in Patients with COVID-19 20.07.2021 / 07:00 Relief Reports that its U.S. Collaboration Partner has Presented Evidence that Aviptadi [ … ]
Technical analysis
To the publication
Tue, 13.07.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, and Quantum Leap Announce Treatment of Severely Ill COVID-19 Patients with Aviptadil in the I-SPY COVID Trial 13.07.2021 / 07:00 Relief Therapeutics Reports that Collaboration Partner [ … ]
Technical analysis
To the publication
Tue, 29.06.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Acquisition Relief and APR Applied Pharma Research Sign and Close Definitive Agreement for Relief to Acquire All Outstanding Shares of APR 29.06.2021 / 07:00 Relief and APR Applied Pharma Research Sign and Close Definitive Agreement for Relief to Acquire All Outstand [ … ]
Technical analysis
To the publication
Mon, 21.06.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): AGMEGM Relief Announces the Results of the Annual General Meeting 2021 of RELIEF THERAPEUTICS Holding AG: All Proposals Approved by a Large Majority 21.06.2021 / 07:00 Relief Announces the Results of the Annual General Meeting 2021 of RELIEF THERAPEUTICS Holding AG [ … ]
Technical analysis
To the publication
Wed, 16.06.2021       RELIEF THERAPEUTICS Holdings AG
CH0100191136

EQS Group-News: RELIEF THERAPEUTICS Holdings AG / Key word(s): Study results Relief Therapeutics Reports that Collaboration Partner, NRx Pharmaceuticals, has Announced Additional Results from the Aviptadil U.S. Expanded Access Protocol for Patients with Critical COVID-19 16.06.2021 / 07:00 Relief Therapeutics Reports that Collab [ … ]
Technical analysis
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Sunday, 06.10.2024, Calendar Week 40, 280th day of the year, 86 days remaining until EoY.